Accreditation/Credit Designation
ACCME Credits
Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physicians’ Education Resource®, LLC, designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Credit Reciprocity
Through an agreement between the American Medical Association and the European Union of Medical Specialists, physicians may convert AMA PRA Category 1 Credit™ to an equivalent number of European CME Credits® (ECMECs®). Information on the process of converting AMA PRA Category 1 Credits™ to ECMECs® can be found at: www.eaccme.eu.
Acknowledgment of Commercial Support
This activity is supported by an educational grant from Amgen, Inc.
Optimizing Use of T-Cell–Engaging Immunotherapy for the Treatment of Acute Lymphoblastic Leukemia
Release Date: November 30, 2021
Expiration Date: November 30, 2022
Activity Overview
Acknowledgement of Commercial Support
This activity is supported by an educational grant from Amgen, Inc.
Instructions for This Activity and Receiving Credit
You may immediately download your certificate. |
Target Audience
Learning Objectives
At the conclusion of this activity, you should be better prepared to:
- Describe the biology of ALL in terms of biomarkers, testing strategies, and methods to stratify risk
- Outline the role of measurable residual disease status in treatment decisions for patients with ALL with T-cell–engaging immunotherapy
- Incorporate key findings from recent clinical trials concerning the use of T-cell–engaging immunotherapy treatment strategies for patients with ALL in the frontline and relapsed/refractory (R/R) settings
Faculty, Staff, and Planners’ Disclosures
The staff of Physicians’ Education Resource®, LLC have no relevant financial relationships with ineligible companies.
Chair
Professor of Medicine, Department of Leukemia
The University of Texas MD Anderson Cancer Center
Houston, Texas, USA
Disclosures: Grant/Research Support: Amgen Inc.; Pfizer Inc.; Takeda Pharmaceutical Company; Adaptive Biotechnologies; Novartis Pharmaceuticals Corporation; Spectrum Pharmaceuticals, Inc.; AbbVie Inc.; Bristol Myers Squibb.
Faculty
Director Medical Research Hematology Unit
Romagnolo Scientific Institute for the Study and Treatment of Cancer
Meldola, Italy
Disclosures: Claudio Cerchione, MD, PhD, has no relevant financial relationships with ineligible companies.
Professor of Medicine
Chair, Department of Leukemia
Samsung Distinguished University Chair in Cancer Medicine
The University of Texas MD Anderson Cancer Center
Houston, Texas, USA
Disclosures: Grant/Research Support: AbbVie, Amgen, Ascentage Pharma, Bristol Myers Squibb, Daiichi-Sankyo, ImmunoGen, Jazz, Pfizer, Sanofi.
Associate Professor of Medicine
Autonomous University of Barcelona
Director, Stem Cell Transplantation Unit
Head, Clinical Hematology Department, Catalan Institute of Oncology
Germans Trias University Hospital
Badalona, Spain
Disclosures: Grant/Research Support: Incyte, Pfizer; Consultant: Amgen, Novartis, Takeda, Pfizer
PER® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.
Off-Label Disclosure and Disclaimer
This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a health care professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.
Login or Register to Start Activity
Please use the form below to Register or Log In to begin Activity.